Hong Kong Launches Expedited Drug Registration Process & Becomes ICH Observer

 
• By Vibha Sharma

Hong Kong is taking incremental steps to move towards a system where it can evaluate and approve new drugs more quickly and efficiently on its own. The moves include preparations for a new Hong Kong Centre for Medical Products Regulation.

The national flag of Hong Kong on a capsule and pills on a spoon
Hong Kong Is Gradually Building Capacity To Be Able To Undertake Independent Drug Evaluations • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards